Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update

This policy documents billing/coding requirements for the Cancer TYPE ID (RT-PCR 92-gene) test: as of 2012-11-19 the test has a DEX Z-Code and that identifier must be reported adjacent to the CPT code on Part A and Part B claims, with '1' entered in the Days/Unit field and an appropriate ICD-10-CM diagnosis code selected. MolDX requires the test to be ordered only by the treating physician.

"MolDX expects Cancer TYPE ID to be ordered only by the treating physician."

Sign up to see full coverage criteria, indications, and limitations.